Fresh2 Group Limited (FRES)
- Previous Close
0.5786 - Open
0.6600 - Bid --
- Ask --
- Day's Range
0.5650 - 0.6600 - 52 Week Range
0.3000 - 9.1700 - Volume
130,266 - Avg. Volume
172,419 - Market Cap (intraday)
14.195M - Beta (5Y Monthly) 1.47
- PE Ratio (TTM)
-- - EPS (TTM)
-7.2600 - Earnings Date May 17, 2024 - May 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
fresh2.coRecent News: FRES
Performance Overview: FRES
Trailing total returns as of 4/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FRES
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FRES
Valuation Measures
Market Cap
14.20M
Enterprise Value
14.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.09
Price/Book (mrq)
1.11
Enterprise Value/Revenue
0.83
Enterprise Value/EBITDA
-0.11
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-61.97%
Return on Equity (ttm)
-216.23%
Revenue (ttm)
16.98M
Net Income Avi to Common (ttm)
-136.42M
Diluted EPS (ttm)
-7.2600
Balance Sheet and Cash Flow
Total Cash (mrq)
649k
Total Debt/Equity (mrq)
0.18%
Levered Free Cash Flow (ttm)
-39.31M